NL157012B - PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH ANTI-INFLAMMATORY ACTION, PREPARED PRODUCTS SO OBTAINED, AND PROCESS FOR PREPARING ANTI-INFLAMMATORY EFFECTIVE HETEROCYCLICAL COMPOUNDS. - Google Patents

PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH ANTI-INFLAMMATORY ACTION, PREPARED PRODUCTS SO OBTAINED, AND PROCESS FOR PREPARING ANTI-INFLAMMATORY EFFECTIVE HETEROCYCLICAL COMPOUNDS.

Info

Publication number
NL157012B
NL157012B NL6715532.A NL6715532A NL157012B NL 157012 B NL157012 B NL 157012B NL 6715532 A NL6715532 A NL 6715532A NL 157012 B NL157012 B NL 157012B
Authority
NL
Netherlands
Prior art keywords
inflammatory
preparation
pharmaceutical preparations
prepared products
effective
Prior art date
Application number
NL6715532.A
Other languages
Dutch (nl)
Other versions
NL6715532A (en
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51823/66A external-priority patent/GB1145884A/en
Priority claimed from GB5620366A external-priority patent/GB1206403A/en
Priority claimed from GB2626267A external-priority patent/GB1147626A/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of NL6715532A publication Critical patent/NL6715532A/xx
Publication of NL157012B publication Critical patent/NL157012B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NL6715532.A 1966-11-18 1967-11-15 PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH ANTI-INFLAMMATORY ACTION, PREPARED PRODUCTS SO OBTAINED, AND PROCESS FOR PREPARING ANTI-INFLAMMATORY EFFECTIVE HETEROCYCLICAL COMPOUNDS. NL157012B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB51823/66A GB1145884A (en) 1966-11-18 1966-11-18 Thiazole derivatives
GB5620366A GB1206403A (en) 1966-12-15 1966-12-15 Oxazoles
GB2507667 1967-05-31
GB2626267A GB1147626A (en) 1966-07-15 1967-06-07 Thiazole derivatives
GB2738267 1967-06-14

Publications (2)

Publication Number Publication Date
NL6715532A NL6715532A (en) 1968-05-20
NL157012B true NL157012B (en) 1978-06-15

Family

ID=27516268

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6715532.A NL157012B (en) 1966-11-18 1967-11-15 PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH ANTI-INFLAMMATORY ACTION, PREPARED PRODUCTS SO OBTAINED, AND PROCESS FOR PREPARING ANTI-INFLAMMATORY EFFECTIVE HETEROCYCLICAL COMPOUNDS.

Country Status (12)

Country Link
JP (1) JPS4938267B1 (en)
BE (1) BE706625A (en)
CH (9) CH545310A (en)
DE (2) DE1795822C2 (en)
ES (1) ES347319A1 (en)
FI (1) FI50416C (en)
FR (2) FR8018M (en)
IL (1) IL28803A (en)
LU (1) LU54891A1 (en)
NL (1) NL157012B (en)
PL (1) PL72562B1 (en)
SE (2) SE369307B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096994A1 (en) * 1970-07-24 1972-03-03 Roussel Uclaf 2-para-cyclopropyl phenyl-4-(halo)phenyl-5-thiazolyl - alkanoic acids -antiinflammatory analgesic, antipyretic agents
JPS5113375U (en) * 1974-07-18 1976-01-30
JPS5182675A (en) * 1975-01-17 1976-07-20 Tokyo Shibaura Electric Co
GB1543154A (en) * 1975-05-02 1979-03-28 Lilly Industries Ltd Urea and carbamate derivatives
US4168315A (en) * 1977-09-28 1979-09-18 The Upjohn Company Dianisyl thiazole compound, compositions and method of antithrombotic treatment
US4697012A (en) * 1984-07-25 1987-09-29 Merck & Co., Inc. Morpholino pyridyl thiazole compound
IT1204751B (en) * 1986-01-03 1989-03-10 Therapicon Srl WATER SOLUBLE ACID DERIVATIVES 4,5 -DIPHENYL-2 -XSAZOLPROPIONIC, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS
DK0934937T3 (en) 1990-11-30 2002-04-02 Otsuka Pharma Co Ltd Azole derivatives as superoxide radical inhibitor
EP1125932A3 (en) * 1994-07-27 2001-08-29 G.D. Searle & Co. Substituted thiazoles for the treatment of inflammation
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130759C (en) * 1965-10-07

Also Published As

Publication number Publication date
DE1795822C2 (en) 1982-07-15
CH556351A (en) 1974-11-29
PL72562B1 (en) 1974-08-30
JPS4938267B1 (en) 1974-10-16
FI50416C (en) 1976-03-10
CH528531A (en) 1972-09-30
CH554884A (en) 1974-10-15
CH545310A (en) 1973-12-15
CH545308A (en) 1973-12-15
BE706625A (en) 1968-05-16
LU54891A1 (en) 1968-02-08
IL28803A (en) 1974-05-16
FR1584222A (en) 1969-12-19
CH536311A (en) 1973-04-30
DE1670005A1 (en) 1970-08-06
CH545309A (en) 1973-12-15
DE1670005C2 (en) 1982-06-09
NL6715532A (en) 1968-05-20
ES347319A1 (en) 1969-05-16
SE369307B (en) 1974-08-19
FR8018M (en) 1970-08-03
SE422209B (en) 1982-02-22
FI50416B (en) 1975-12-01
CH560205A5 (en) 1975-03-27
CH560203A5 (en) 1975-03-27

Similar Documents

Publication Publication Date Title
NL145226B (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH DIURETIC AND ANTIHYPERTENSIVE ACTION, THEREFORE PREPARED MEDICINAL PRODUCT AND A PROCESS FOR THE PREPARATION OF MEDICINAL COMPOUNDS.
NL141187B (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANALGETIC AND ANTI-INFLAMMATORY ACTION, PREPARED MEDICINAL PRODUCT THEREOF, AND PROCESS FOR PREPARING MEDICINAL COMPOUNDS.
NL142872B (en) PROCESS FOR THE PREPARATION OF BASIC NITROGEN COMPOUNDS WITH SPASMOLYTIC AND / OR VASOLIDICULATING ACTION; PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND OBJECTS THEREFORE OBTAINED.
NL146709B (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH BETA-ADRENOLYTIC ACTION, THE MEDICINAL PRODUCTS OBTAINED BY THE APPLICATION OF THIS PROCESS, AND A PROCESS FOR PREPARING BETA-ADRENOLYTIC ALPINE-2-PHENOLYTIC ACTIVE ALXANDRO-3-PHEN-3-PHENROXANDY-3-ALXANDROXAMINES
NL147414B (en) PROCESS FOR THE PREPARATION OF PHENOXYACETIC ACID DERIVATIVES WITH HYPOCHOLESTEROLEMIC ACTION AND OF PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AND PREPARED PRODUCTS THEREFORE OBTAINED.
NL139233B (en) PROCESS FOR THE PREPARATION OF COMPOUNDS WITH CORONAR VESSEL-REMOVING ACTION, AS WELL AS PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL AND FORMED PREPARATIONS.
NL139972B (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTIFLOGISTICAL AND ANALGETICAL ACTION.
NL157012B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH ANTI-INFLAMMATORY ACTION, PREPARED PRODUCTS SO OBTAINED, AND PROCESS FOR PREPARING ANTI-INFLAMMATORY EFFECTIVE HETEROCYCLICAL COMPOUNDS.
NL148611B (en) PROCESS FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE DERIVATIVES OF 7-AMINOCEPHALOSPORANIC ACID, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND PREPARED PRODUCTS SO OBTAINED.
NL161434B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH ALPHA SYMPATHICOLYTIC ACTION, FORMED PREPARATIONS AND PROCEDURE FOR THE PREPARATION OF AMINOALKYL-TETRAHYDRO 1-KETONEAPHTALENE DERIVATIVES.
NL159110B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH ANTI-LEUKEMIC AND ANTI-INFLAMMATORY ACTION, THE FORMED PRODUCTS OBTAINED THROUGH THE APPLICATION AND PROCESS FOR THE PREPARATION OF ANTI-LEUKEMIC AND ANTI-INFLAMMATORY EFFECTS.
NL151058B (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH HYPOCHOLESTEROLEMIC ACTION, MEDICINAL PRODUCT SO OBTAINED AND PROCESS FOR THE PREPARATION OF MEDICINAL COMPOUNDS.
NL139969B (en) PROCESS FOR THE PREPARATION OF UNSATURATED KETO-CARBONIC ACIDS WITH DIURETIC AND SALURETIC ACTION, AND PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AND THE PREPARATIONS PREPARED THEREOF.
NL148037B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS AND THE ARTICLES MANUFACTURED BY THEIR USE, AND PROCEDURE FOR PREPARING ANTI-INFLAMMATORY, ANALGESIC, ANTIPYRETIC AND ANTIPPURITIC COMPOUNDS.
NL152554B (en) PROCESS FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE PREPARATIONS AND FEED, FORMED PRODUCTS AND PREPARATION OF USEFUL SUBSTANCES.
NL151383B (en) PROCESS FOR PREPARING 3-OXO- (DELTA) 4 * 9-19-NORANDROSTADIENES WITH ANABOLIC AND ANDROGEN ACTION; PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS AND THE PREPARATIONS THEREFORE PREPARED.
NL7512107A (en) PROCESS FOR THE PREPARATION OF ANTI-INFLAMMATORY PHARMACEUTICAL PREPARATIONS, THE OBJECTS OBTAINED BY THEIR APPLICATION AND PROCESS FOR THE PREPARATION OF COMPOUNDS WITH ANTI-INFLAMMATORY ACTION.
NL155010B (en) PROCEDURE FOR PREPARING PHARMACEUTICAL PREPARATIONS, PROCESS FOR PREPARING MEDICINAL COMPOUNDS FOR THIS, AND PREPARATIONS THEREFORE.
NL161449C (en) PROCESS FOR THE PREPARATION OF 4-ALKYLAMINOMETHYL-1,3-DIOXOLAN COMPOUNDS WITH ANALGETIC ACTION, PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS USING COMPOUNDS, PREPARATORED PREVENTED ARMS
NL148237B (en) METHOD FOR THE PREPARATION OF MUCOLYTICALLY ACTIVE PREPARATIONS.
NL153517B (en) PROCESS FOR PREPARING SUBSTITUTED PHENYLACEETAMIDES WITH ANTI-INFLAMMATORY, ANALGETIC, ANTIPYRETIC AND UV-LIGHT-ABSORBING ACTION, PROCESS FOR PREPARING PHARMACEUTICAL AND COSMETIC PREPARATIONS, AND PREPARATIONS.
NL145760B (en) PROCESS FOR THE PREPARATION OF ANTHELMINTIC ACTIVE MEDICINAL PRODUCTS AND FEEDS AND FORMED MEDICINAL PRODUCTS AND FEEDS OBTAINED.
NL166267C (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS, THE PRODUCTS PRODUCED THEREOF, AND PROCESS FOR THE PREPARATION OF 6,7-METHYLENE-20-SPIROX-4-AND-3-RINDERMONDERED PRODUCTS.
NL152170B (en) PROCESS FOR PREPARING ANTIBIOTICALLY ACTIVE RIFAMYCINE DERIVATIVES; PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND THE PREPARATIONS THEREFORE OBTAINED.
NL159109B (en) PROCESS FOR THE PREPARATION OF CYTOSTATICALLY ACTIVE DERIVATIVES OF FLUORINATED PYRIMIDINENUCLEOSIDES, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH CYTOSTATIC ACTION AND THE FORMED PHARMACEUTICAL PREPARATIONS.

Legal Events

Date Code Title Description
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: WYETH

V4 Discontinued because of reaching the maximum lifetime of a patent